Brentuximab ni iki: Ibikoreshwa, Urutonde rw'imiti, Ingaruka ziterwa n'ibindi

Brentuximab ni umuti w'indwara ya kanseri ugamije gufasha kurwanya ubwoko bumwe na bumwe bwa kanseri y'amaraso, cyane cyane lymphoma. Ni icyo abaganga bita "monoclonal antibody-drug conjugate," bivuze ko ihuriza hamwe poroteyine ibona selile za kanseri hamwe n'umuti wa chimiotherapi uzisenya. Uyu muti utangwa binyuze mu gutera urushinge mu rwego rwo hejuru mu biro bya muganga cyangwa mu bitaro, kandi ugamije kwibanda ku selile za kanseri mu gihe selile zifite ubuzima bwiza zirinzwe kurushaho.

Brentuximab ni iki?

Brentuximab ni umuti wihariye wa kanseri ukora nk'igisasu kiyobowe ku bwoko bumwe na bumwe bwa kanseri y'amaraso. Uyu muti uhuza ibice bibiri bikomeye: umubiri urwanya indwara ushakisha poroteyine zihariye kuri selile za kanseri, n'umuti wa chimiotherapi utangwa mu buryo butaziguye kuri izo selile. Ubu buryo bugamije gufasha umuti gukora neza cyane kandi bishobora gutera ingaruka nke ugereranije na chimiotherapi isanzwe.

Uyu muti wibanda by'umwihariko kuri poroteyine yitwa CD30, iboneka ku gice cyo hejuru cya selile za kanseri zimwe na zimwe. Iyo brentuximab ibonye izo selile, yifatanya nazo ikarekurira umuti wa chimiotherapi imbere muri selile ya kanseri. Iki gikorwa cyo kwibanda neza ni cyo gituma brentuximab itandukana n'imiti ya kanseri ya kera igira ingaruka ku selile zifite ubuzima bwiza n'izirwaye kanseri.

Brentuximab ikoreshwa mu iki?

Brentuximab ikoreshwa cyane cyane mu kuvura ubwoko bwihariye bwa lymphoma, ari kanseri zigira ingaruka ku mikorere y'imitsi yawe. Muganga wawe ashobora kugutera uyu muti niba ufite Hodgkin lymphoma cyangwa ubwoko bumwe na bumwe bwa T-cell lymphoma zagarutse nyuma yo kuvurwa cyangwa zitagaragaje igisubizo ku bundi buryo bwo kuvura.

Uyu muti akenshi ukoreshwa iyo izindi nshuti zitagize icyo zikora nk'uko byari byitezwe, cyangwa iyo kanseri yagarutse nyuma yo gukira. Rimwe na rimwe abaganga bakoresha brentuximab nk'igice cy'umugambi wo kuvura, bakorana n'indi miti ya kanseri kugira ngo baguhe umusaruro mwiza ushoboka. Umuganga wawe w'inzobere mu by'indwara ya kanseri azamenya niba ubwoko bwawe bwihariye bwa lymphoma bufite poroteyine ya CD30 ituma brentuximab ikora neza.

Brentuximab ikora ite?

Brentuximab ikora nk'umuti wa kanseri ukomeye, ugamije, kandi ukora neza kurusha imiti gakondo ya chemotherapy. Tekereza nk'uburyo bwo gutanga bujyana chemotherapy mu buryo butaziguye mu turanduriro twa kanseri mugihe cyo kurengera cyane ibice by'umubiri bifite ubuzima. Uyu muti ugenda mu maraso yawe kugeza ubona uturanduriro dufite poroteyine ya CD30 ku gasozi kacyo.

Iyo brentuximab yifatanye n'uturanduriro twa kanseri, yinjizwa imbere aho irekurira umuti wa chemotherapy ukomeye witwa monomethyl auristatin E (MMAE). Uyu muti noneho wangiza ubushobozi bw'uturanduriro twa kanseri bwo kwigabanya no gukura, amaherezo bigatuma uturanduriro dupfa. Kubera ko chemotherapy itangwa mu buryo butaziguye mu turanduriro twa kanseri, urashobora guhura n'ingaruka nke zikwirakwira zisanzwe za chemotherapy gakondo.

Nkwiriye gufata brentuximab nte?

Brentuximab itangwa nka infusion ya intravenous (IV), bivuze ko itangwa mu buryo butaziguye mu maraso yawe binyuze mu urugingo. Uzafata ubu buvuzi mu biro bya muganga wawe, mu ivuriro ry'abarwayi batari mu bitaro, cyangwa mu bitaro, kandi ubu buryo busanzwe bufata iminota nka 30. Uyu muti akenshi utangwa rimwe mu byumweru bitatu, nubwo muganga wawe azagena gahunda nyayo ashingiye ku miterere yawe yihariye.

Mbere yo guterwa urushinge, ntugomba kwirinda kurya cyangwa kunywa, ariko bifasha kuguma ufite amazi ahagije mu mubiri no kurya ifunguro ryoroshye mbere yaho. Itsinda ry'abaganga bazakugenzura mu gihe cyo guterwa urushinge no nyuma yarwo kugira ngo barebe niba hari icyo wahura nacyo ako kanya. Ushobora kumva umeze neza uramutse uzanye igitabo, tablet, cyangwa ibindi bikorwa byo kwinezeza byagufasha kwirinda umwanya mu gihe uvurwa.

Muganga wawe ashobora kuguha imiti mbere yo guterwa urushinge rwa brentuximab kugira ngo afashe kwirinda ibimenyetso byo kwivumbura cyangwa isesemi. Iyi

Nk'uko imiti yose ivura kanseri ibigenza, brentuximab ishobora gutera ingaruka ziterwa n'imiti, nubwo abantu benshi bayihanganira neza. Ingaruka zikunze kugaragara ushobora guhura nazo muri rusange zirashobora gucungwa neza hakoreshejwe uburyo bwiza bwo kwita ku buzima no gukurikiranwa n'ikipe yawe y'ubuzima.

Dore ingaruka zikunze kugaragara abantu benshi bahura nazo mugihe bavurwa na brentuximab:

• Kugira umunaniro no kumva urushye kurusha uko bisanzwe
• Isesemi no kuruka rimwe na rimwe
• Impiswi cyangwa impinduka mu myifatire y'amara
• Peripheral neuropathy (kumva ibintu bishushanya cyangwa guhumirwa mu ntoki no mu birenge)
• Urubore n'ubukonje
• Umutwe
• Urugo rwo ku ruhu cyangwa kuribwa
• Kugabanya ubushake bwo kurya
• Urubavu cyangwa kubabara mu ngingo

Izi ngaruka ziterwa n'imiti mubisanzwe zoroheje kugeza hagati kandi akenshi ziragenda zikira umubiri wawe umaze kumenyera umuti. Ikipe yawe y'ubuzima ishobora gutanga imiti n'uburyo bwo gufasha gucunga ibi bimenyetso neza.

Hariho kandi n'izindi ngaruka zikomeye zisaba kwitabwaho ako kanya, nubwo zitagaragara cyane. Izi zirimo kwangirika gukomeye kw'imitsi bitera guhumirwa cyangwa intege nke zikomeye, indwara zikomeye ziterwa no kugabanuka kw'imirimo y'umubiri y'ubwirinzi, n'indwara y'ibihaha idasanzwe ariko ikomeye yitwa pneumonitis. Byongeye kandi, abantu bamwe bashobora guhura na tumor lysis syndrome, aho selile za kanseri zisenyuka vuba cyane ku buryo bigira ingaruka ku mikorere y'impyiko.

Ingaruka imwe yihariye yo kwitondera ni peripheral neuropathy, ishobora gutera kumva ibintu bishushanya, guhumirwa, cyangwa kubabara mu ntoki no mu birenge. Ibi bikunda kugaragara cyane kuri brentuximab kurusha uko biba mu zindi miti ivura kanseri, kandi ni ngombwa kumenyesha muganga wawe guhumirwa cyangwa kumva ibintu bishushanya vuba. Mu bihe byinshi, iyi ngaruka iterwa n'imiti irahinduka, cyane cyane iyo ifashwe hakiri kare.

Ninde utagomba gufata Brentuximab?

Brentuximab ntiribereye buri wese, kandi muganga wawe azasuzuma neza niba ari wo mwanzuro ukwiriye kubera ibibazo byawe byihariye. Abantu bafite indwara zimwe na zimwe cyangwa abafata imiti imwe na imwe bashobora gukenera ubuvuzi bundi cyangwa gukurikiranwa byihariye.

Ntabwo ukwiriye guhabwa brentuximab niba ufite allergie ikomeye izwi ku muti cyangwa ibice byawo byose. Byongeye kandi, niba ufite indwara zikomeye zikora, muganga wawe ashobora gushaka kuzivura mbere yo gutangira brentuximab, kuko umuti ushobora kugira ingaruka ku bushobozi bwa sisitemu yawe y'ubudahangarwa bwo kurwanya indwara.

Muganga wawe azitonda cyane mu gutanga brentuximab niba ufite ibibazo by'imitsi, indwara y'umwijima, cyangwa ibibazo by'impyiko. Abantu bafite amateka y'ibibazo by'umutima bashobora kandi gukenera gukurikiranwa byihariye, kuko imiti imwe na imwe ya kanseri ishobora kugira ingaruka ku mikorere y'umutima. Niba utwite cyangwa wonka, brentuximab muri rusange ntisabwa, kuko ishobora gukomeretsa abana bakiri bato.

Niba wigeze guhabwa bleomycin (undi muti wa kanseri), muganga wawe azagereranya neza ibyago n'inyungu, kuko hashobora kubaho ibyago byiyongereye by'ibibazo by'ibihaha iyo iyi miti ikoreshwa hamwe. Abantu bafite sisitemu y'ubudahangarwa yagabanutse biturutse ku zindi mpamvu nabo bashobora gukenera kwitabwaho byihariye mbere yo gutangira kuvurwa.

Amazina ya Brentuximab

Brentuximab izwi cyane ku izina ryayo Adcetris. Iri ni ryo zina uzabona ku byapa byawe by'imiti no mu mpapuro z'ubwishingizi. Izina risanzwe ryuzuye ni brentuximab vedotin, ryerekana uruvange rwihariye rw'umubiri urwanya indwara (brentuximab) n'umuti wa chemotherapy (vedotin yerekeza ku gice cya monomethyl auristatin E).

Iyo uvugana n'ikipe yawe y'ubuvuzi, ikigo cy'ubwishingizi, cyangwa umufarumasiti, ushobora gukoresha "Adcetris" cyangwa "brentuximab vedotin" - bazasobanukirwa ko uvuga ku muti umwe. Inyandiko zimwe na zimwe z'ubuvuzi zishobora gukoresha inyuguti ngufi "BV" kuri brentuximab vedotin, ikoreshwa cyane mu buvuzi bw'indwara zifata imitsi.

Uburyo bwo gusimbuza Brentuximab

Niba brentuximab atari wo muti ukwiriye kuri wowe, hari ubundi buryo bwo kuvura bushobora kuboneka bitewe n'ubwoko bwawe bw'umuvumbyi. Umuganga wawe w'inzobere mu kuvura kanseri azatekereza ku bintu nk'ubuzima bwawe muri rusange, imiti wakoresheje mbere, n'imiterere yihariye ya kanseri yawe igihe avuga ku buryo bwo gusimbuza.

Ku muvumbyi wa Hodgkin, uburyo bwo gusimbuza bushobora kuba bukubiyemo imiti gakondo ihuriza hamwe nka ABVD (adriamycin, bleomycin, vinblastine, dacarbazine) cyangwa uburyo bushya bwo kuvura bugamije ibintu runaka nka nivolumab cyangwa pembrolizumab, bikora bafasha urugero rwawe rw'umubiri kurwanya kanseri. Abantu bamwe bashobora kuba bakwiriye gukoreshwa imiti ya CAR-T, aho uturemangingo twawe tw'umubiri tuhindurwa kugira ngo turwanye neza uturemangingo twa kanseri.

Ku muvumbyi runaka w'uturemangingo twa T, izindi nzira zishobora kuba zikubiyemo imiti nka romidepsin, belinostat, cyangwa pralatrexate. Ibizamini by'ubuvuzi bikorwa mu gushakisha uburyo bushya bwo kuvura bugamije ibintu runaka na byo bikunze kuboneka, kandi muganga wawe ashobora kugufasha gusobanukirwa niba hari imiti igeragezwa ishobora kuba ikwiriye kuri wowe.

Gu hitamo hagati y'ibi bisubizo biterwa n'ibintu byinshi, harimo uburyo kanseri yawe yitwayeho ku miti yakoreshejwe mbere, uko ubuzima bwawe bumeze muri rusange, n'ibyo wifuza ku bijyanye n'imbaraga z'imiti n'ingaruka zayo.

Ese Brentuximab iruta izindi miti ivura umuvumbyi?

Niba brentuximab ari "nziza" kurusha izindi miti ivura lymphoma biterwa n'uko ubuzima bwawe bumeze, ubwoko bwa lymphoma ufite, n'ubuzima bwawe bwite. Ku bwoko bumwe bwa lymphoma, cyane cyane izifite selile za CD30-positive, brentuximab yagaragaje ibisubizo byiza kandi ishobora gukora neza kurusha imiti gakondo ya chemotherapy yonyine.

Mu bushakashatsi bwakozwe, brentuximab yagaragaje urwego rwo gusubiza mu buryo butangaje kuri lymphoma ya Hodgkin yagarutse cyangwa yanze gukira, akenshi ikora neza kabone n'iyo izindi miti yananiwe. Imiterere y'iyi miti igamije kandi isobanura ko abantu benshi bagira ingaruka nke zikomeye zijyana na chemotherapy gakondo, nk'isuka ikabije, umusatsi ugenda, cyangwa igabanuka rikomeye ry'imibare y'amaraso.

Ariko, "nziza" buri gihe ni imvugo mu kuvura kanseri. Abantu bamwe basubiza neza kuri chemotherapy gakondo kandi ntibakeneye imiti igamije. Abandi bashobora kungukirwa n'uburyo bushya bwo kuvura kanseri. Muganga wawe w'inzobere mu by'ubuvuzi yitaho ibintu byinshi iyo asaba imiti, harimo imiterere yihariye ya kanseri yawe, ubuzima bwawe muri rusange, imiti yabanje, n'intego zawe bwite n'ibyo ukunda.

Ikintu cy'ingenzi ni ukubona uburyo bwo kuvura buguha amahirwe meza yo kugenzura lymphoma yawe mugihe ukomeza ubuzima bwawe bwiza. Ibi akenshi bikubiyemo uruvange rwawe rwa terapiya zitandukanye aho kwishingikiriza ku muti umwe "mwiza".

Ibikunze Kubazwa Kuri Brentuximab

Q1. Ese Brentuximab irakwiriye abantu bafite indwara z'umutima?

Brentuximab irashobora gukoreshwa ku bantu bafite indwara z'umutima, ariko bisaba gukurikiranwa neza no guhuza ibikorwa hagati ya muganga wawe w'inzobere mu by'ubuvuzi n'umuganga w'umutima. Nubwo brentuximab ubwayo idasanzwe itera ibibazo by'umutima, abantu bamwe bakira imiti ivura kanseri bashobora guhura n'imihindukire mu mikorere y'umutima, cyane cyane niba baragize ibibazo by'umutima mbere cyangwa bakiriye izindi miti ivura kanseri ishobora kugira ingaruka ku mutima.

Muganga wawe ashobora gutegeka ibizamini by'imikorere y'umutima mbere yo gutangira brentuximab kandi ashobora gukurikirana umutima wawe mugihe cy'imiti. Niba ufite amateka y'ibibazo by'umutima, gerageza kubiganiraho neza n'ikipe yawe y'ubuzima kugirango bashobore gukora gahunda y'imiti itekanye kuri wowe.

Q2. Nkwiriye gukora iki niba mbonye brentuximab nyinshi mu buryo butunganye?

Kubera ko brentuximab itangwa nabaganga mubikorwa byubuvuzi, kwiyongera kwibitera byabayeho cyane. Imiti ibarwa neza hakurikijwe uburemere bwawe kandi itangwa nabaganga cyangwa abaganga bitoza basuzuma kabiri imiti mbere ya buri terwa.

Niba ufite impungenge kubijyanye n'urugero rwawe cyangwa ubona ibimenyetso bikomeye bitunguranye nyuma y'imiti, hamagara ikipe yawe y'ubuzima ako kanya. Barashobora gusuzuma uko uhagaze kandi bagatanga ubuvuzi bukwiye. Ibidukikije byubuvuzi bigenzurwa aho brentuximab itangirwa bitanga uburyo bwinshi bwo kugenzura umutekano kugirango birinde amakosa yo gutanga imiti.

Q3. Nkwiriye gukora iki niba nasibye urugero rwa brentuximab?

Niba wasibye terwa rya brentuximab ryateganyijwe, hamagara ikipe yawe y'ubuzima vuba bishoboka kugirango usubize gahunda. Ntugerageze "gufata" ufite imiti ibiri hafi - ibi birashobora kongera ibyago byo kugira ingaruka mbi hatagize icyo bigeraho cyiza cyimiti.

Muganga wawe azagena uburyo bwiza bwo gusubira kuri gahunda, bishobora gushobora guhindura gahunda yawe yimiti gato. Gusiba urugero rumwe mubisanzwe ntigira ingaruka zikomeye kumusaruro wawe wimiti, ariko birakenewe gukomeza gahunda ihamye uko bishoboka kugirango ubone ibisubizo byiza.

Q4. Nshobora guhagarika ryari gufata brentuximab?

Ukwiye guhagarika imiti ya brentuximab gusa mugihe umuganga wawe wihariye yemeje ko bikwiye kubikora. Iyi myanzuro ishingiye kuburyo lymphoma yawe isubiza neza imiti, ingaruka mbi urimo guhura nazo, n'intego zawe zose z'imiti. Ntukigere uhagarika brentuximab wenyine, niyo wumva umeze neza.

Umuganga wawe azajya asuzuma uko urimo utera imbere binyuze mu bipimo by'amaraso no mu mashusho. Niba kanseri yawe irimo igaragara neza, ushobora kurangiza umubare wateganyijwe w'inzego hanyuma ugakomereza mu gihe cyo gukurikiranwa. Niba urimo guhura n'ingaruka zikomeye, umuganga wawe ashobora guhindura gahunda yawe yo kuvurwa cyangwa agatekereza uburyo bwo kuvura butandukanye.

Q5. Nshobora Kugenda Ndi Kuvurwa na Brentuximab?

Ubusanzwe ushobora kugenda uri kuvurwa na brentuximab, ariko bisaba gutegura no guhuza ibikorwa n'ikipe yawe y'ubuzima. Kubera ko umuti utangwa buri byumweru bitatu, uzakenera gutegura urugendo rwawe ukurikije gahunda yo guhabwa imiti. Umuganga wawe kandi azashaka kumenya niba ufite uburyo bwo kwivuza aho ugiye mu gihe wahura n'ingaruka zose.

Mbere yo kujya mu rugendo, ganira ku migambi yawe na muganga wawe w'inzobere mu kuvura kanseri, cyane cyane niba ugiye mu mahanga cyangwa ahantu hatari kure. Bashobora kuguha inyandiko z'ubuvuzi, guhindura gahunda yawe yo kuvurwa niba bibaye ngombwa, cyangwa bakaguha abaganga bo kugufasha aho ugiye. Ni byiza kandi kugenda ufite urutonde rw'imiti yawe n'amakuru yo guhamagara umuganga wawe.